13F Notebook
← Dashboard
Fund detail

Viking Global Investors (Halvorsen)

hedge-fund, active

Quarters 52
2021-03-31 $33.58B
Positions 94
Showing 10 of 10 rows (filtered from 124)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 BRIDGEBIO PHARMA INC BBIO $1.64B 4.88% 26,620,991 +0 +0.00% 5.21% 2019-06-30 $62 ~$27 +128.40%
2 ADAPTIVE BIOTECHNOLOGIES COR ADPT $1.21B 3.60% 29,993,708 +0 +0.00% 4.88% 2019-06-30 $40 ~$48 -16.65%
3 API GROUP CORP APG $689.3M 2.05% 33,333,333 +0 +0.00% 1.66% 2020-06-30 $21 ~$12 +70.21%
4 4D MOLECULAR THERAPEUTICS IN FDMT $170.8M 0.51% 3,937,914 +0 +0.00% 0.45% 2020-12-31 $43 ~$41 +4.66%
5 SNOWFLAKE INC SNOW $143.8M 0.43% 627,157 +0 +0.00% 0.49% 2020-09-30 $229 ~$251 -8.65%
6 UNITY SOFTWARE INC U $141.4M 0.42% 1,409,981 +0 +0.00% 0.60% 2020-09-30 $100 ~$87 +14.93%
7 INHIBRX INC INBXUSD $106.5M 0.32% 5,305,866 +0 +0.00% 0.48% 2020-09-30 $20 ~$18 +11.50%
8 DOORDASH INC DASH $80.1M 0.24% 610,573 +0 +0.00% 0.24% 2020-12-31 $131 ~$143 -8.14%
9 KINNATE BIOPHARMA INC KNTEUSD $58.3M 0.17% 1,872,023 +0 +0.00% 0.20% 2020-12-31 $31 ~$40 -21.67%
10 ATHIRA PHARMA INC $39.0M 0.12% 2,120,653 +0 +0.00% 0.20% 2020-09-30 $18 ~$18 -0.32%